FDA to review and potentially overhaul PMTA rules amid lawsuit and illicit market concerns
FDA announced it is reviewing its experience with the Premarket Tobacco Product Application (PMTA) rule and recent court actions.
The agency cites the growth of an illicit market and rapid introduction of new products as reasons to consider a modernized framework that offers clearer guidance.
While any rule changes would follow legal procedures and include public comment, the FDA will continue processing existing PMTA submissions and making decisions under current law.
The move reflects the FDA’s commitment to the Tobacco Control Act and its goal of protecting public health through a more predictable regulatory environment.
This writeup was produced by pharmadog from original reporting by fda press.
Original headline: “FDA intends to evaluate changes to the PMTA regulatory framework”
read at fda press ↗
comments(0)
5-min edit window · permanent after that